GlassScriptPhysician profile
Solly Abraham
NPI 1932246436
$3,973.70
in general payments reported to CMS, 2019-2025
42 companies · $1,122 in 2025
The $1,122 reported for 2025 was more than what 86% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $457 · 2022: $739 · 2023: $1,207 · 2024: $449 · 2025: $1,122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,777.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,777.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $516.60 | 2021-2025 | Xtampza, Belbuca |
| Abbvie INC. | $290.91 | 2022-2023 | |
| Boston Scientific Corporation | $265.24 | 2022-2025 | Wavewriter Alpha Prime 16 |
| Vertos Medical, INC. | $184.56 | 2022-2023 | Mild Device Kit |
| Fresenius Kabi USA, LLC | $181.44 | 2024 | Smoflipid, Kabiven |
| Astrazeneca Pharmaceuticals LP | $177.00 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $148.73 | 2022-2025 | Xifaxan, Relistor |
| Neurocrine Biosciences, INC. | $140.00 | 2025 | |
| Saluda Medical Americas, INC. | $125.48 | 2023-2025 | Evoke Scs, Evoke |
| Alexion Pharmaceuticals, INC. | $115.68 | 2023 | Soliris |
| Phathom Pharmaceuticals, INC. | $109.84 | 2025 | Voquezna |
| Idorsia Pharmaceuticals US INC | $105.49 | 2023 | Quviviq |
| Grifols USA, LLC | $103.48 | 2025 | Prolastin-C Liquid |
| Mallinckrodt Hospital Products INC. | $103.32 | 2023 | Terlivaz |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $100.00 | 2025 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Solly Abraham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.